Specialty code 183500000X · Anaheim, CA
NPI
1891987277
Since 2007
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
539 S Morningstar Dr
Anaheim, CA, 92808
Phone (714) 685-1563
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.7M
660 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Azar Nazari prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 137 prescriptions and refills. In total Azar Nazari wrote 660 Medicare prescriptions that cost $3.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 137 | 359 | 60 | $1.3M |
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 85 | 85 | 31 | $557K |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 40 | 110 | 31 | $1,938 |
| Ritonavir Generic | 34 | 98 | 16 | $4,794 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 25 | 71 | 16 | $235K |
| Tivicay Dolutegravir Sodium | 24 | 62 | 13 | $164K |
| Descovy Emtricitabine/Tenofov Alafenam | 23 | 61 | 17 | $128K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 23 | 65 | 14 | $234K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 22 | 66 | Under 11 | $237K |
| Dovato Dolutegravir Sodium/Lamivudine | 22 | 48 | Under 11 | $149K |
| Darunavir Generic | 22 | 58 | 11 | $5,097 |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 21 | 62 | 14 | $2,376 |
| Prezcobix Darunavir/Cobicistat | 18 | 48 | 15 | $121K |
| Juluca Dolutegravir/Rilpivirine | 18 | 50 | 17 | $176K |
| Isentress Raltegravir Potassium | 16 | 46 | Under 11 | $99K |
Brand drugs: 444 claims; generic drugs: 216 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Azar Nazari were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.